Abstract: Compounds, methods, uses, compositions, kits and packages for the treatment of imbalance between bone resorption and bone formation, based on uses of 4-phenyl-2 propionamidotetralin (4-P-PDOT) and analogs, derivatives, prodrugs, precursors thereof, and salts thereof, are described.
Abstract: The present invention relates to deoxyribozymes targeting and cleaving HCV RNA. More particularly, the present invention relates to deoxyribozymes and composition used for the inhibition of HCV replication and HCV-related diseases.
Type:
Application
Filed:
September 10, 2008
Publication date:
August 13, 2009
Applicant:
Chu Sainte-Justine, Le Centre Hospitalier Universitaire Mere-Enfant
Inventors:
Carolina Alfieri, Janie Trepanier, Jerome E. Tanner, Richard Momparler